Bank of America’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Buy |
|
|||||
|
2025
Q1 | $181K | Sell |
|
|||||
|
2024
Q4 | $246K | Buy |
|
|||||
|
2024
Q3 | $199K | Sell |
|
|||||
|
2024
Q2 | $230K | Buy |
|
|||||
|
2024
Q1 | $271K | Sell |
|
|||||
|
2023
Q4 | $743K | Buy |
|
|||||
|
2023
Q3 | $289K | Sell |
|
|||||
|
2023
Q2 | $383K | Sell |
|
|||||
|
2023
Q1 | $457K | Sell |
|
|||||
|
2022
Q4 | $839K | Buy |
|
|||||
|
2022
Q3 | $731K | Buy |
|
|||||
|
2022
Q2 | $321K | Buy |
|
|||||
|
2022
Q1 | $271K | Sell |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $1.25M | Sell |
|
|||||
|
2021
Q2 | $1.39M | Buy |
|
|||||
|
2021
Q1 | $1.5M | Buy |
|
|||||
|
2020
Q4 | $593K | Buy |
|